MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced today the launch of a national campaign designed to raise awareness of sudden cardiac arrest (SCA), its risk factors, and the role of implantable cardioverter-defibrillator (ICD) therapy in saving lives. SCA is the one of the nation’s leading causes of death – claiming more lives than breast cancer, lung cancer, and HIV/AIDS combined1,2,3.
